author-photo

Brian Stouch

Amgen

9

Papers

1637

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double‐blind, placebo‐controlled study

2014 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (133)
OP0044 The effects of multiple doses of sclerostin antibody AMG 785 in healthy men and postmenopausal women with low bone mass

2013 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (2)
Effects of multiple doses of the sclerostin antibody AMG 785 in healthy men and postmenopausal women with low bone mass

2012 Bone
Show All
- Source
- Cite
- Save
Citations (2)
Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies

2011 Clinical Pharmacokinectics
Show All
- Source
- Cite
- Save
Citations (117)
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys☆ , ☆☆

2011 Bone
Show All
- Source
- Cite
- Save
Citations (74)
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

2011 Journal of Bone and Mineral Research
Show All
- Source
- Cite
- Save
Citations (650)
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

2010 Journal of Bone and Mineral Research
Show All
- Source
- Cite
- Save
Citations (210)
Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

2010 Journal of Bone and Mineral Research
Show All
- Source
- Cite
- Save
Citations (356)